NO308855B1 - Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein - Google Patents

Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein

Info

Publication number
NO308855B1
NO308855B1 NO933269A NO933269A NO308855B1 NO 308855 B1 NO308855 B1 NO 308855B1 NO 933269 A NO933269 A NO 933269A NO 933269 A NO933269 A NO 933269A NO 308855 B1 NO308855 B1 NO 308855B1
Authority
NO
Norway
Prior art keywords
leu
immunodeficiency virus
human immunodeficiency
polypeptides derived
polypeptide
Prior art date
Application number
NO933269A
Other languages
English (en)
Norwegian (no)
Other versions
NO933269L (no
NO933269D0 (no
Inventor
Francesca Chiodi
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of NO933269D0 publication Critical patent/NO933269D0/no
Publication of NO933269L publication Critical patent/NO933269L/no
Publication of NO308855B1 publication Critical patent/NO308855B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/974Aids related test
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO933269A 1991-03-15 1993-09-14 Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein NO308855B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,296 US5229364A (en) 1991-03-15 1991-03-15 Polypeptides derived from the human immunodeficiency virus endonuclease protein
PCT/US1992/001813 WO1992016219A1 (en) 1991-03-15 1992-03-03 Polypeptides derived from the human immunodeficiency virus endonuclease protein

Publications (3)

Publication Number Publication Date
NO933269D0 NO933269D0 (no) 1993-09-14
NO933269L NO933269L (no) 1993-11-12
NO308855B1 true NO308855B1 (no) 2000-11-06

Family

ID=24689836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933269A NO308855B1 (no) 1991-03-15 1993-09-14 Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein

Country Status (13)

Country Link
US (2) US5229364A (fi)
EP (1) EP0575522B1 (fi)
JP (1) JPH07119235B2 (fi)
AT (1) ATE166068T1 (fi)
AU (1) AU683812B2 (fi)
CA (1) CA2105664C (fi)
DE (1) DE69225473T2 (fi)
DK (1) DK0575522T3 (fi)
ES (1) ES2118131T3 (fi)
FI (1) FI111731B (fi)
IE (1) IE920832A1 (fi)
NO (1) NO308855B1 (fi)
WO (1) WO1992016219A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein
CA2124797C (en) * 1991-12-23 2004-03-30 Bruce D. Irvine Hiv probes for use in solution phase sandwich hybridization assays
US5590213A (en) * 1995-02-15 1996-12-31 David Clark Company Inc. Headset with adjustable headpad
DE19717187A1 (de) * 1997-04-24 1998-10-29 Pagendarm Technologie Gmbh Vorrichtung zur Behandlung, insbesondere Trocknung von Materialbahnen
KR20060032138A (ko) * 2003-05-12 2006-04-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 에프아이브이 감염에 대항하여 면역화를 위한 물질 및 방법
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
CA2742918A1 (en) * 2008-11-17 2010-05-20 Dow Global Technologies Llc Methods for reducing airborne formaldehyde

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620330B2 (en) * 1987-05-29 1992-02-20 Smithkline Beckman Corporation Immunodiagnostic assays using chimeric antigens
FR2640877A1 (fi) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
WO1990010230A1 (en) * 1989-02-23 1990-09-07 University Of Ottawa Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
US5229364A (en) * 1991-03-15 1993-07-20 Francesca Chiodi Polypeptides derived from the human immunodeficiency virus endonuclease protein

Also Published As

Publication number Publication date
FI111731B (fi) 2003-09-15
NO933269L (no) 1993-11-12
CA2105664C (en) 1998-08-25
EP0575522A4 (en) 1994-11-23
AU1572592A (en) 1992-10-21
JPH07119235B2 (ja) 1995-12-20
NO933269D0 (no) 1993-09-14
ATE166068T1 (de) 1998-05-15
AU7546896A (en) 1997-02-20
US5229364A (en) 1993-07-20
ES2118131T3 (es) 1998-09-16
JPH06505275A (ja) 1994-06-16
DE69225473T2 (de) 1998-10-01
WO1992016219A1 (en) 1992-10-01
US5401628A (en) 1995-03-28
EP0575522A1 (en) 1993-12-29
DK0575522T3 (da) 1998-10-07
AU671950B2 (en) 1996-09-19
FI934022A (fi) 1993-09-14
CA2105664A1 (en) 1992-09-16
AU683812B2 (en) 1997-11-20
DE69225473D1 (de) 1998-06-18
FI934022A0 (fi) 1993-09-14
IE920832A1 (en) 1992-09-23
EP0575522B1 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
ATE236981T1 (de) Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
ATE85809T1 (de) Herstellung des menschlichen von-willebrandfaktors durch rekombinante dns.
NO933269L (no) Polypeptider avledet fra humanimmunsviktvirusets endonukleaseprotein
DE69131662D1 (de) Lipopeptide, T-cytotoxische Lymphocyte aktivierend, und deren Verwendung als Vakzine
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
ATE121754T1 (de) Vakzine gegen bordetella.
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DK0426314T3 (da) HIV-relaterede peptider
DE3886443D1 (de) Menschliche Rhinoviruspeptide.
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.

Legal Events

Date Code Title Description
MK1K Patent expired